Login
CannTrust Holdings OTC Market: CNTTQ
Our growing facility is a 430,000-square foot greenhouse in the heart of the Niagara region. The facility is the first of its kind in the Canadian Cannabis industry to be designed and engineered using advanced perpetual growing technology. This facility is one of the largest in North America, with Phase 1 completed and Phase 2 to come on-line in 2019
| Name | CannTrust Holdings |
| Ticker | CNTTQ |
| Exchange | OTC Market |
| Sector | Health Care |
| Industry | Cannabis Producer |
|
Price
52W Low/High |
0.59
0.16 / 0.94 |
| Momentum | Neutral |
| Market cap | 62 M |
| 1Y Total Return |
51.28%
Average |
| 1Y Volatility |
131.67%
High Risk |
Our growing facility is a 430,000-square foot greenhouse in the heart of the Niagara region. The facility is the first of its kind in the Canadian Cannabis industry to be designed and engineered using advanced perpetual growing technology. This facility is one of the largest in North America, with Phase 1 completed and Phase 2 to come on-line in 2019
Details
| Ticker | CNTTQ |
| Name | CannTrust Holdings |
| ISIN | CA1378002077 |
| CUSIP | 137800207 |
| Exchange | OTC Market |
| Sector | Health Care |
| Industry | Cannabis Producer |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 6/17/2021
| Close Price | 0.59 |
| 52W Low/High | 0.16 / 0.94 |
| Market cap | 62 M |
| 1Y Total Return |
51.28%
Average |
| 1Y Volatility |
131.67%
High Risk |
| Beta | -0.06 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -29.7% |
| Cash from Op. / Cur. Liabilities | -1.22 |
| Diluted Earnings / Share | -0.14 |
| ROE | - |
| ROIC | -11.3% |
| Price / Revenue | 1.3 |
| Price / Book | 0.3 |
| Price / CF | -2.9 |
| Current Ratio | 7.6 |
| Cur.Liabilities / Tot.Liabilities | 0.6 |
| Financial Leverage | 0.08 |
| in Mils USD |
rolling-year up to December
|
|||
|---|---|---|---|---|
| Income Statement | 2018 | 2017 | 2016 | |
| Revenue |
46
|
21
|
4
|
|
| Gross Profit |
36
|
24
|
4
|
|
| R&D |
0
|
0
|
0
|
|
| EBITDA |
-8
|
9
|
-12
|
|
| Operating Income |
-9
|
9
|
-2
|
|
| Net Income exc. Extra |
-
|
7
|
-
|
|
| per Share | ||||
| Diluted avg Shares |
99
|
81
|
43
|
|
| EPS exc. Extra |
-0.14
|
0.09
|
-0.32
|
|
| Dividend |
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
|
| Balance Sheet | 2018 | 2017 | 2016 | |
| Total Assets |
202
|
78
|
17
|
|
| Cash, Eq & Invt ShortTerm |
72
|
18
|
5
|
|
| Total Current Assets |
128
|
44
|
12
|
|
| Total Non-Current Assets |
74
|
34
|
5
|
|
| Intangibles |
0
|
0
|
0
|
|
| Total Liabilities |
28
|
8
|
6
|
|
| Total Current Liabilities |
17
|
7
|
4
|
|
| Long Term Debt |
11
|
1
|
3
|
|
| Shareholder equity |
174
|
71
|
10
|
|
| Cash Flow | 2018 | 2017 | 2016 | |
| Cash from Operations |
-20
|
-1
|
-2
|
|
| Depreciation |
4
|
2
|
1
|
|
| Cash from Investing |
-110
|
-31
|
-1
|
|
| Capex |
33
|
24
|
1
|
|
| Cash from Financing |
121
|
44
|
5
|
|
| Stock Issued |
109
|
45
|
4
|
|
| Debt (LT) Issued |
13
|
0
|
1
|
|
| Free Cash Flow |
-67
|
-22
|
-13
|
|
| Ratios | 2018 | 2017 | 2016 | |
| Net Profit Margin |
-
|
33.3%
|
-
|
|
| NCFO / Op.Income |
-
|
-5.7%
|
-
|
|
| Current Ratio |
7.6
|
6.5
|
3.3
|
|
| Financial Leverage D/E |
0.08
|
0.01
|
0.24
|
|
| Return on Capital Avg |
-11.3%
|
23.1%
|
-156.7%
|
|
| Return on Shareholder Equity |
-
|
16.9%
|
-
|
|
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available